Aura Biosciences, Inc. / Fundamentals
Income statement
- Net revenue
€0.00 - Cost of goods sold
€507.08K - Gross profit
-€257.40K - SG&A expenses
€19.81M - R&D expenses
€73.44M - EBITDA
-€66.16M - D&A
€775.63K - EBIT
-€68.34M - Interest expenses
€0.00 - EBT
-€86.87M - Tax expenses
€83.23K - Net income
-€86.98M
Cash flow statement
- Net deferred tax
€0.00 - Non-cash items
-€838.27K - Changes in working capital
€3.83M - Operating cash flow
-€71.52M - Capex
€743.03K - Other investing cash flow
€0.00 - Net investing cash flow
€76.68M - Total cash dividends paid
€0.00 - Issuance of common stock
€59.71M - Debt repayment
€0.00 - Other financing cash flow
€1.16M - Net financing cash flow
€61.16M - Foreign exchange effects
-€10.30K - Net change in cash
€66.32M - Cash at end of period
€92.78M - Free cash flow
-€70.77M
Balance sheet
- Cash and cash equivalents
€92.12M - Cash and short-term investments
€152.13M - Total receivables
€0.00 - Inventory
€0.00 - Other current assets
€5.70M - Total current assets
€157.84M - Property, plant & equipment
€16.72M - Goodwill
€0.00 - Intangible assets
€0.00 - Long-term investments
€658.94K - Other non-current assets
€158.73K - Total non-current assets
€17.54M - Total assets
€175.37M - Accounts payable
€1.10M - Short-term debt
€5.48M - Other current liabilities
€6.16M - Total current liabilities
€12.74M - Long-term debt
€25.60M - Deferred tax liabilities
€0.00 - Other non-current liabilities
€0.00 - Total non-current liabilities
€12.80M - Total liabilities
€25.54M - Common stock
€0.00 - Retained earnings
-€367.85M - Other equity
€21.45K - Total equity
€149.83M - Total liabilities and shareholders' equity
€175.37M
Company information
- Market capitalization
€332.13M - Employees
106 - Enterprise Value
€391.31M
Company ratios
- Gross margin
-
0.0% - EBITDA margin
-
0.0% - EBIT margin
-
0.0% - EBT margin
-
0.0% - Net margin
-
0.0% - ROE
-
-58.1% Much better than peer group: -268.1% - ROA
-
-49.6% Much better than peer group: -123.0% - Asset turnover
-
0.0% - FCF margin
-
0.0% - FCF yield
-21.8% - Efficiency ratio
0.0% - Net sales per employee
-
€0.00 - Net income per employee
-
-€820.59K